Healthcare -
Biotechnology - NASDAQ - US
$ 0.1906
1.87 %
$ 12.5 M
Market Cap
-0.13
P/E
LYRA - STOCK-BASED COMPENSATION
Stock-based Compensation LYRA - Lyra Therapeutics, Inc.
5.89 M
LAST VALUE
45.78%
2 YEAR CAGR
70.72%
5 YEAR CAGR
0.00%
10 YEAR CAGR